/RGEDF
RGEDF Stock - Gedeon Richter PLC
Healthcare|Medical - PharmaceuticalsOTC
$29.23+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $32.15
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RGEDF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$28.94 – $29.52
TARGET (TP)$33.61
STOP LOSS$26.89
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.23
52W High$30.92
52W Low$27.17
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $857.54B | $805.16B | $802.75B | $630.60B | $566.78B |
| Gross Profit | $590.74B | $521.32B | $460.46B | $349.27B | $314.46B |
| Gross Margin | 68.9% | 64.7% | 57.4% | 55.4% | 55.5% |
| Operating Income | $256.17B | $189.36B | $168.47B | $139.78B | $126.77B |
| Net Income | $239.24B | $158.85B | $169.08B | $139.63B | $104.68B |
| Net Margin | 27.9% | 19.7% | 21.1% | 22.1% | 18.5% |
| EPS | $1307.00 | $859.72 | $907.39 | $750.65 | $562.90 |
Company Overview
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RGEDFBeat Rate
100%
Last 1 quarters
Avg Surprise
+84.4%
EPS vs Estimate
Beats / Misses
1/0
Last 12 quarters
Latest EPS
$0.00
Q4 2025
EPS Surprise History
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 27, 2026 | — | — | — | — |
Q4 2025 | Nov 6, 2025 | — | $0.00 | — | — |
Q2 2025 | May 12, 2025 | — | $1.01 | — | — |
Q1 2025 | Feb 26, 2025 | — | $0.87 | — | — |
Q4 2024 | Nov 12, 2024 | — | $0.56 | — | — |
Q3 2024 | Aug 6, 2024 | — | $1.04 | — | — |
Q2 2024 | May 14, 2024 | — | $1.01 | — | — |
Q1 2024 | Feb 29, 2024 | — | $0.56 | — | — |
Q3 2023 | Sep 30, 2023 | — | $1.79 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.45 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.60 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.59 | — | — |
Q4 2022 | Nov 8, 2022 | — | $442.00 | — | — |
Q3 2022 | Aug 3, 2022 | — | $411.00 | — | — |
Q2 2022 | May 10, 2022 | — | $199.00 | — | — |
Q1 2022 | Feb 28, 2022 | $135.58 | $250.00 | +84.4% | ✓ BEAT |
Q4 2021 | Nov 8, 2021 | — | $205.00 | — | — |
Q3 2021 | Aug 3, 2021 | — | $151.00 | — | — |
Q2 2021 | May 9, 2021 | — | $145.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RGEDF
What is RGEDF's current stock price?
Gedeon Richter PLC (RGEDF) is currently trading at $29.23 per share. The stock has moved +0.00% today.
What is the analyst price target for RGEDF?
No analyst price targets are currently available for this stock.
What sector is Gedeon Richter PLC in?
Gedeon Richter PLC operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.
What is RGEDF's market cap?
Gedeon Richter PLC has a market capitalization of $5.35 billion, making it a mid-cap company.
Does RGEDF pay dividends?
No, Gedeon Richter PLC does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANSLY
Ansell Limited
$96.27
Mkt Cap: $3.5B
BVNKF
Bavarian Nordic A/S
$30.65
Mkt Cap: $2.4B
GLPGF
Galapagos N.V.
$31.29
Mkt Cap: $2.1B
MAHLY
MediPal Holdings Corporation
$18.03
Mkt Cap: $3.7B
MEPDF
MediPal Holdings Corporation
$16.50
Mkt Cap: $3.4B
RHCGF
Ryman Healthcare Limited
$1.75
Mkt Cap: $1.8B
SDGCF
Sundrug Co.,Ltd.
$28.18
Mkt Cap: $3.3B
SHWGF
Shandong Weigao Group Medical Polymer Company Limited
$0.69
Mkt Cap: $3.1B
SHWGY
Shandong Weigao Group Medical Polymer Company Limited
$2.54
Mkt Cap: $2.9B
ULIHF
The United Laboratories International Holdings Limited
$1.88
Mkt Cap: $3.7B
Explore stocks similar to RGEDF for comparison